BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

AVA Biochem Release: First Industrial Production For Renewable 5-­-HMF


2/3/2014 9:07:33 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Muttenz, Switzerland – 3rd February 2014 – Commercial-­-scale production of the high-­-purity renew-­- able platform chemical, 5-­-Hydroxymethylfurfural (5-­-HMF) has started at the Biochem-­-1 facility oper-­- ated by AVA Biochem in Muttenz, Switzerland. The Swiss-­-made 5-­-HMF is made from renewable feed-­- stock and Biochem-­-1 will, in a first phase, produce up to 20 tonnes 5-­-HMF per year.

AVA Biochem offers a sustainable new material for a wide range of applications and sectors, from chemicals and plastics to food and pharmaceuticals. A subsidiary of AVA-­-CO2, AVA Biochem’s new, innovative production process for 5-­-HMF is based on a modified version of the hydrothermal car-­- bonisation (HTC) process. Various levels of purity -­- up to 99.9% -­- are available. Commercial-­-scale quantities are now available for delivery.

In 2010, 5-­-HMF was identified as one of the top 10 most valuable platform chemicals by the United States Department of Energy. It is intensively being used in the research and development of innova-­- tive new materials and products, such as for polymers, resins and additives.

On announcing the start of commercial-­-scale production, AVA Biochem’s CEO Jan Vyskocil said, “AVA Biochem's breakthrough HTC technology is opening new markets for renewable 5-­-HMF. I am con-­- vinced that this will push us to the forefront of the bio-­-based chemical industry.”

About AVA Biochem

AVA Biochem BSL AG (AVA Biochem) operates the world’s first industrial plant for the production of renewable 5-­-Hydroxymethylfurfural (5-­-HMF, CAS 67-­-47-­-0). A subsidiary of AVA-­-CO2 Schweiz AG, Zug, AVA Biochem has a game-­-changing production process for 5-­-HMF production. Biochem-­-1, the first industrial plant for the production of 5-­-HMF from biomass is located on Clariant’s Infrapark in Mut-­- tenz, Switzerland where AVA Biochem is headquartered. AVA Biochem delivers high-­-purity 5-­-HMF to industrial and research customers around the globe. www.ava-­-biochem.com

High-­-resolution images are available in the Downloads section at www.ava-­-biochem.com.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES